Posted by Michael Wonder on 11 Sep 2017
Agenda for 13 September TC meeting
8 September 2017 - HAS has posted the agenda for the next scheduled TC meeting.
The Transparency Commission will consider the reimbursement of:
- Rolapitant (Varuby)
- Tofacitinib citrate (Xeljanz)
- Ferric ferrocyanide (Radiogardase)
